L2: Update COMM

我们是谁

  • 4 月 5, 2022
    最初无法切除肝转移灶的 RAS/BRAF 野生型结直肠癌患者的转换疗法
  • 4 月 5, 2022
    Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRC
  • 4 月 5, 2022
    CAVE-2 GOIM 研究：阿韦鲁单抗加西妥昔单抗联合疗法作为再挑战策略的临床研究
  • 1 月 1, 1970
    Cadonilimab Combined With Regorafenib as A Third-line Treatment in Patients With MSS CRLM